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Genetic interaction screen for 
severe neurodevelopmental 
disorders reveals a functional 
link between Ube3a and Mef2 in 
Drosophila melanogaster
Jonas Straub1,2, Anne Gregor1,2, Tatjana Sauerer1, Anna fliedner1, Laila Distel1, 
christine Suchy1, Arif B. ekici  1, Fulvia ferrazzi  1 & christiane Zweier1*
neurodevelopmental disorders (nDDs) are clinically and genetically extremely heterogeneous with 
shared phenotypes often associated with genes from the same networks. Mutations in TCF4, MEF2C, 
UBE3A, ZEB2 or ATRX cause phenotypically overlapping, syndromic forms of NDDs with severe 
intellectual disability, epilepsy and microcephaly. To characterize potential functional links between 
these genes/proteins, we screened for genetic interactions in Drosophila melanogaster. We induced 
ubiquitous or tissue specific knockdown or overexpression of each single orthologous gene (Da, Mef2, 
Ube3a, Zfh1, XNP) and in pairwise combinations. Subsequently, we assessed parameters such as 
lethality, wing and eye morphology, neuromuscular junction morphology, bang sensitivity and climbing 
behaviour in comparison between single and pairwise dosage manipulations. We found most stringent 
evidence for genetic interaction between Ube3a and Mef2 as simultaneous dosage manipulation 
in different tissues including glia, wing and eye resulted in multiple phenotype modifications. We 
subsequently found evidence for physical interaction between UBE3A and MEF2C also in human cells. 
Systematic pairwise assessment of the Drosophila orthologues of five genes implicated in clinically 
overlapping, severe NDDs and subsequent confirmation in a human cell line revealed interactions 
between UBE3A/Ube3a and MEF2C/Mef2, thus contributing to the characterization of the underlying 
molecular commonalities.
Neurodevelopmental disorders (NDDs) are clinically and genetically extremely heterogeneous, and currently 
more than 1,000 genes have been implicated (SysID database1). Within the last years, phenotypically and biolog-
ically coherent modules within this large and heterogeneous group have been increasingly delineated, indicating 
that overlapping phenotypes are often caused by mutations in genes involved in the same molecular networks1–5. 
This has been demonstrated mainly for well-defined pathways or complexes such as the RAS-MAPK-pathway4 or 
the SWI/SNF chromatin remodelling complex6, but is less characterized for disease genes involved in a broader 
biological context or process such as transcriptional regulation. Identifying and characterizing such connections 
and correlations contributes to a better understanding of the complex mechanisms and pathomechanisms in 
neurodevelopment and its associated disorders.
Pitt-Hopkins syndrome (PTHS, MIM# 610954), MEF2C-related intellectual disability (MRD20; MIM# 
613443), Mowat-Wilson syndrome (MOWS, MIM# 235730), ATRX-related intellectual disability (ATRX, 
MIM#301040; MRXHF1, MIM#309580) and Angelman syndrome (AS, MIM#105830) represent a particular 
group of syndromic NDDs. They are important differential diagnoses towards each other and share phenotypic 
characteristics such as severe intellectual disability, epilepsy, postnatal microcephaly and some facial features7 
(Fig. 1a). Angelman syndrome is caused by loss of the maternal allele of UBE3A, encoding an ubiquitin-protein 
ligase8,9. PTHS, MRD20 and MOWS are caused by haploinsufficiency of TCF4, MEF2C or ZEB2, respectively, all 
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encoding transcription factors10–12. Also X-chromosomal ATRX, implicated in ATRX-related intellectual disabil-
ity, encodes a transcriptional regulator13.
Drosophila melanogaster has been demonstrated to be a powerful model to investigate functional relationships 
between NDD-associated genes/proteins, given a high conservation of genes, pathways and regulatory networks 
between flies and humans14–17. Drosophila screens for eye, wing and neuronal phenotypes upon RNAi-based 
knockdown of NDD-associated gene orthologues revealed robust correlations between fly and human phenotype 
groups1,18 in terms of phenologs19, thus indicating conservation of functional modules. More specific functional 
relationships between individual genes can be investigated by genetic interaction studies. Genetic interaction 
is defined as the observation that a double mutant’s phenotype deviates from what is expected from each indi-
vidual mutant20. Such approaches, based on quantifiable phenotypes in Drosophila, were utilized to investigate 
multiple-hit and copy number variant (CNV) models as done e.g. for autism spectrum disorders21,22 or to validate 
newly identified NDD-associated candidate genes by establishing biological links to phenotypically overlapping, 
known NDD-associated genes in terms of a chromatin-modification module5.
By utilizing Drosophila melanogaster as a model to screen for genetic interactions, we identified specific 
functional links between several genes in the fly, most stringent between Ube3a and Mef2. This interaction was 
furthermore confirmed in a human cell line using co-immunoprecipitation experiments. These molecular com-
monalities might contribute to the clinically overlapping features of the investigated disorders.
Results
Ubiquitous and tissue specific dosage manipulation in Drosophila melanogaster. To system-
atically investigate functional links between these genes of interest, we used Drosophila melanogaster as an in 
vivo model system and tested genetic interaction between the fly orthologues Mef2 (MEF2C), Zfh1 (ZEB2), 
Daughterless (Da) (TCF4), XNP (ATRX) and Ube3a (UBE3A).
Quantitative reverse transcriptase PCR (RT-PCR) confirmed knockdown (KD) to 35–70% residual levels and 
3 to 8.5fold overexpression (OE) for all used lines (Supplementary Table S1) except for Zfh1 (Supplementary 
Fig. S1). Overexpression of Zfh1 resulted in early lethality, preventing quantitative RT-PCR, and knockdown 
could not be shown (Supplementary Fig. S1), leading to exclusion of the KD_Zfh1-line from subsequent experi-
ments. To evaluate the possibility of overlapping phenotypes resulting from dosage manipulation of Ube3a, Mef2, 
Da, XNP or Zfh1 and to identify quantifiable phenotypes for subsequent genetic interaction experiments, we 
induced knockdown (four genes) or overexpression (five genes) either ubiquitously or in several different tissues 
and evaluated parameters such as viability, morphological alterations, synapse development and gross neurolog-
ical behaviour (Fig. 1b).
Ubiquitous knockdown of two of the four tested genes (Mef2 and Da) and overexpression of all five tested 
genes resulted in lethality. Wing specific knockdown resulted in morphological phenotypes for two genes (Mef2, 
Da), and wing specific overexpression resulted in (male) lethality or morphological wing phenotypes for all five 
genes (Table 1, Figs. 2, S2). Eye-specific knockdown resulted in morphological phenotypes for two genes (Mef2, 
Da), and eye-specific overexpression resulted in lethality or morphological phenotypes for four of the genes 
(Ube3a, Mef2, Da, Zfh1) (Table 1, Figs. 3, S3).
Nervous system specific knockdown either pan-neuronally or in glia cells did not result in reduced viability. 
However, pan-neuronal overexpression of either Zfh1, Da or Ube3a or glial overexpression of either Zfh1, Da, 
XNP or Mef2 resulted in variable lethality phenotypes (Tables 1 and S2). Evaluation of several parameters of larval 
Figure 1. Genes of interest and study outline. (a) Five syndromic NDDs with considerable phenotypic overlap 
were selected. AS, Angelman syndrome; MOWS, Mowat-Wilson syndrome; MRD20, mental retardation, 
autosomal dominant 20 (MEF2C haploinsufficiency syndrome); MRHXF1, mental retardation-hypotonic 
facies syndrome/ATRX, alpha-thalassemia-mental retardation syndrome; PTHS, Pitt-Hopkins syndrome (b) 
Schematic drawing of the study outline and the work flow. (c) Overview of results from genetic interaction 
studies in Drosophila. Black lines indicate gene-gene connections investigated in this study by one (thin line), 
two (middle line) or four (thick line) different combinations. Magenta lines indicate genetic interactions 
between two genes, respectively. Genetic interaction was defined here as the observation of multiple phenotypic 
modifications upon pairwise dosage manipulation in several tissues. Solid magenta line indicates strongest 
evidence for genetic interaction with several consistent phenotypic modifications observed in different 
tissues. Dashed line in magenta indicates evidence for a possible genetic interaction with some phenotypic 
modifications observed. Single or inconsistent phenotypic modifications are not indicated.
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neuromuscular junctions (NMJs) such as NMJ area, NMJ length, number of islands, branches, boutons or active 
zones did not reveal any consistent alterations in synaptic morphology upon either pan-neuronal knockdown or 
overexpression of any of the genes (Supplementary Fig. S4). We did not observe a satellite bouton phenotype (data 
not shown) as previously described in an Ube3a mutant23. This might be related to a weaker knockdown of the 
RNAi line. Furthermore, gross neurological functioning was tested using the climbing assay upon pan-neuronal 
knockdown or overexpression. We found that overexpression of Da or XNP resulted in a mild climbing defect, 
respectively, and that overexpression of Ube3a led to a severe climbing deficit (Supplementary Fig. S5). Additional 
testing of seizure susceptibility with the bang sensitivity assay (Supplementary Table S3) did not reveal consistent 
phenotypes for any of the tested KD and OE lines.
Genetic interaction screen. Based on the location of RNAi- or UAS-elements on chromosomes 2 or 3, 
we could create three lines combining two KD elements each, eight lines combining two OE elements each, 
and twelve lines combining KD with OE elements each (Table 1, Fig. 1c). By quantitative RT-PCR we found no 
condition ubi. wing eye neur. glia
single knockdown
KD_Ube3a_1 N N N18 N N
KD_Ube3a_2 N N N N N
KD_Mef2 L P (curled, alt. veins)62 P (bubbles) N N
KD_Da (L) P1 P (red. bristles),18 N N
KD_XNP N N1 N18 N N
single overexpression
OE_Ube3a_1 L mL,P (curled) P (rough) (L) N
OE_Ube3a_2 L (mL),P P (rough) N N
OE_Mef2 L P33 P (red. bristles) N mL, (L)
OE_Da L mL,P L (mL) L
OE_XNP L P (crumbled, curled, alt. veins) N N L
OE_Zfh1 L L L L L
pairwise manipulation
KD_Ube3a_1;KD_Mef2 L P↑ P ↑ N N
OE_Ube3a_1;OE_Mef2 L mL, P↓ P ↓ (L) L↓
KD_Ube3a_1;OE_Mef2 L P P N L↓
OE_Ube3a_1;KD_Mef2 L mL,P↓ (mL)↓, P↓ L↓ L↓
KD_Ube3a;KD_XNP N N N N N
OE_Ube3a_1;OE_XNP L mL,P P (L) L
KD_Ube3a_1;OE_XNP L P↓ N N (L)
OE_Ube3a_1;KD_XNP L (mL)↑, P P mL ↓ N
KD_Ube3a_1; KD_Da (L) P P N N
OE_Da;OE_Ube3a_2 L mL,P L (mL) L
OE_Da;KD_Ube3a_2 L (L)↓ L (mL) L
OE_Ube3a_1;KD_Da L (mL),P P (L)↓ N
OE_Da;OE_Mef2 L (L)↓ (L) N(↑) L
OE_Da;KD_Mef2 L mL,P L (mL) L
OE_Da;OE_XNP L mL,P mL↑,P (mL) L
OE_Da;KD_XNP L mL,P L (mL)(↓) L
OE _Zfh1;OE_Ube3a_2 L L L L L
OE_Zfh1;KD_Ube3a_2 (L) L L L L
OE_Zfh1;OE_Mef2 L L L L L
OE_Zfh1;KD_Mef2 L L L L L
OE_Zfh1;OE_XNP L L L L L
OE _Zfh1;KD_XNP L L L L L
OE_Zfh1;KD_Da L L L L L
Table 1. Viability and morphology upon tissue-specific dosage manipulation. Ubi., ubiquitous; neur., pan-
neuronal; N, normal viability and normal morphology; L, lethality; mL, male lethality; P, morphological 
phenotype; ↑, milder phenotype compared to single KD or OE; ↓, more severe phenotype compared to single 
KD or OE; (), incomplete penetrance or borderline phenotype/modification; some of the phenotypes have 
been reported previously for the same line or condition; References indicate reports with similar phenotypic 
observations (absence of phenotype or presence of identical phenotype) in previous studies.
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indication that distribution of GAL4 between two UAS-elements would dilute its effect (Supplementary Fig. S1). 
We tested all combinations for lethality and wing and eye morphology phenotypes. NMJ morphology, bang sen-
sitivity and climbing behaviour were assessed for the three KD combination constructs and for the eight OE 
combinations.
Phenotypic modifications were considered as a) additive, when the combined phenotype represented the sum 
of the two single phenotypes, b) as antagonistic, when the combined phenotype was milder than the more severe 
of the two single phenotypes, and c) as synergistic, when the combined phenotype was different or more severe 
than what was expected from the sum of the two single phenotypes.
In the evaluation of viability and gross morphologic eye and wing phenotypes upon ubiquitous and tissues 
specific dosage manipulation we observed several modified phenotypes in the pairwise combinations (Table 1). 
We considered those most indicative of a true genetic interaction, where modified phenotypes occurred at least 
in three different KD/OE combinations and tissues and were markedly milder (antagonistic) or more severe or 
different than expected from adding the single phenotypes (synergistic) (Fig. 1c).
Figure 2. Genetic interaction of Ube3a and Mef2 or XNP in the Drosophila wing (ms1096-GAL4). (a) 
Knockdown (KD) of Ube3a does not cause a wing phenotype, KD of Mef2 causes abnormally curled wings 
in male flies with additional cross vein defects, such as missing anterior cross veins and/or ectopic cross 
veins (marked with an arrow). Simultaneous KD of Ube3a and Mef2 results in a milder phenotype with 
significantly more flies with both cross veins present and fewer flies with ectopic cross veins, quantified in (b). 
(c) Overexpression (OE) of Ube3a causes abnormally curled wings in females, while KD of Mef2 does not cause 
a phenotype in female flies (male phenotype see above). Simultaneous OE of Ube3a and KD of Mef2 results in 
male lethality and in a more severe disorganization of wing architecture in about 75% of females, as quantified 
in (d). (e) OE of XNP causes abnormally curled wings in female flies with additional cross vein defects, such 
as missing anterior cross veins and/or ectopic cross veins (marked with an arrow). Simultaneous KD of Ube3a 
(normal) and OE of XNP results in a more severe phenotype with more flies with ectopic cross veins and fewer 
flies with both cross veins intact, as quantified in (f). Statistical analysis was performed using Fisher’s Exact 
test, **p ≤ 0.001; ***p ≤ 0.0001). Flies are counted towards the more severe phenotype if at least one wing was 
affected. These results are from an independent experiment than in Supplementary Table S2, thus numbers are 
different.
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The most robust interaction was observed between Ube3a and Mef2. Combined knockdown in either wing 
(Fig. 2a,b) or eye (Fig. 3a,b) resulted in an amelioration of the phenotype observed in the single conditions. Wing 
venation defects as well as the rough eye with loss of ommatidia integrity, resulting in bubble-like appearance of 
the eye surface, improved. Pairwise overexpression of Mef2 and Ube3a in either wing or eye led to a worsening 
of phenotypes. In the wing, the only mildly abnormal, curled wings in females from each of the single condi-
tions were severely disorganized and not fully unfolded in the combined overexpression (Supplementary Fig. S1). 
While each of the single overexpression conditions was associated with a mild eye phenotype only, their com-
bination resulted in a severe eye malformation with markedly reduced size and dissolved ommatidia structure 
(Fig. 3c,d). Overexpression of Ube3a and simultaneous knockdown of Mef2 in either wing or eye also resulted in 
increased phenotypic severity, compared to the single conditions. Wings showed a severe disorganization in 75% 
of the females, which was not present in the single manipulations (Fig. 2c,d, Table 1). In the eye, the same com-
bination resulted in partial male lethality and progressive necrotic patches in eyes of females (Fig. 3e,f, Tables 1 
and S2). While pan-neuronal knockdown of Mef2 did not affect viability and while pan-neuronal overexpres-
sion of Ube3a only resulted in partial lethality, a combination of these conditions resulted in complete lethality 
(Tables 1, S2). A similar observation was made for glial deregulation. There, simultaneous overexpression of both 
and simultaneous overexpression of Mef2 with knockdown of Ube3a and vice versa resulted in complete lethality, 
while the single conditions were viable or only lethal in males (Tables 1, S2).
In summary, we have identified multiple phenotypic modifications upon pairwise dosage manipulation of 
Ube3a and Mef2. The synergistic or antagonistic direction of an interaction was dependent on the combination of 
KD and OE conditions and consistent across multiple tissues for each specific combination.
Also for combined dosage manipulation of Ube3a and XNP, phenotypic modifications were observed for 
several combinations and tissues. Simultaneous overexpression of Ube3a and knockdown of XNP in the wing 
resulted in increased viability of male flies (6% in OE_Ube3a alone and 39% in OE_Ube3a; KD_XNP, p < 0.001, 
Figure 3. Genetic interaction of Mef2 and Ube3a in the Drosophila eye (GMR-GAL4). (a) Knockdown (KD) 
of Ube3a does not cause a phenotype, KD of Mef2 causes rough eyes with more severely affected flies also 
displaying a bubble-like appearance. Simultaneous KD of Ube3a and Mef2 results in a milder phenotype with 
significantly fewer eyes with bubble-like appearance, quantified in (b) (***: p ≤ 0.001, Fisher’s Exact test). (c) 
Overexpression (OE) of Ube3a causes rough eyes, OE of Mef2 results in a mildly reduced number of bristles but 
grossly intact ommatidial structure. Simultaneous OE of both results in a severe phenotype with reduced eye 
size and dissolved ommatidia structure in all eyes as quantified in (d). (e) Simultaneous OE of Ube3a (rough 
eye) and KD of Mef2 (rough eyes and occasionally bubble-like appearance) results in a different and more severe 
phenotype with disorganized ommatidia structure and progressive necrosis as quantified for male and female 
flies in (f). Pictures and quantifications are from male flies if not indicated otherwise.
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Fisher’s exact test) and therefore in an improvement of the phenotype. In contrast, simultaneous knockdown of 
Ube3a and overexpression of XNP in the wing led to a more severe phenotype in the females, with stronger dis-
organization of cross veins compared to the phenotype in the single lines (Fig. 2e,f, Tables 1, S2). Pan-neuronal 
overexpression of Ube3a in combination with knockdown of XNP resulted in worsening of incompletely pen-
etrant lethality in females (20% of balancer flies in OE_Ube3a_1 alone and 10% in OE_Ube3a_1;KD_XNP, 
p < 0.05, Fisher’s exact test) and complete lethality in males (76% vs. 0%, compared to females, p < 0.05, and 23% 
vs. 0%, compared to balancer flies, p < 0.0001, Fisher’s exact test).
Pairwise manipulations of other tested genes did not result in multiple or consistent phenotypic modifications. 
When we evaluated the climbing assay upon pairwise dosage manipulations, we observed a significantly increased 
climbing impairment of the OE_Da;OE_XNP construct compared to the respective single conditions, which, 
however, might represent an additive effect of both single gene conditions. No other consistent modifications of 
the observed single phenotypes were observed (Supplementary Fig. S5). Analysis of NMJ morphology and bang 
sensitivity upon pairwise dosage manipulations did not reveal any phenotypic modifications (Supplementary 
Fig. S4, Supplementary Table S3).
Protein co-localization and interaction. To investigate whether UBE3A and MEF2C also physically 
interact, we performed co-localization and co-immunoprecipitation studies in human cell lines. Firstly, we 
could confirm that UBE3A and MEF2C both localize to the nucleus as described previously24 when simulta-
neously overexpressed in HeLa cells, indicating that a physical interaction is possible (Fig. 4a). Subsequently, 
we could show that UBE3A and MEF2C can be co-immunoprecipitated from HEK293 cells co-transfected 
with Myc-tagged UBE3A and HA-tagged MEF2C. This was true for immunoprecipitation of either Myc-tagged 
UBE3A or HA-tagged MEF2C, suggesting that they indeed form a direct or indirect interaction (Figs. 4b, S6). 
Using quantitative RT-PCR, we tested if UBE3A/Ube3a or MEF2C/Mef2 might regulate transcriptional levels of 
each other. We did not find evidence for transcriptional effects as in fly larvae Mef2 levels were unaltered upon 
Ube3a knockdown and vice versa (Supplementary Fig. S1). Furthermore, also in human cells (HEK293) MEF2C 
expression levels were unaltered upon UBE3A knockdown using siRNAs (Supplementary Fig. S7).
Discussion
Though it has increasingly been acknowledged that similar clinical neurodevelopmental phenotypes are caused 
by mutations in genes/proteins connected in common networks and processes, this has mostly been characterized 
for specific complexes or pathways (e.g2,4.) or on a more systematic, large scale but consequently less detailed1,18 
level. We now investigated possible functional links between TCF4, MEF2C, ZEB2, UBE3A and ATRX which 
are all implicated in clinically overlapping, severe human neurodevelopmental disorders. To do this, we utilized 
Figure 4. Physical interaction of human MEF2C and UBE3A in cells. (a) Co-localization studies of 
overexpressed human tagged MEF2C (HA, red) and UBE3A (Myc, green) in HeLa cells show diffuse 
nuclear localization of both proteins. (b) Co-immunoprecipitation experiments show physical interaction of 
overexpressed human MEF2C and UBE3A in HEK293 cells. Immunoprecipitation of Myc-tagged UBE3A also 
precipitates MEF2C-HA and vice versa. Please note, that the figure panels are cropped from two different blots 
with different exposure times. For full blots see Supplementary Fig. S6.
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Drosophila melanogaster as a model system to systematically investigate functional links between the orthologues 
of these genes/proteins (Da, Mef2, Zfh1, Ube3a, XNP) in vivo.
Drosophila lethality and morphological phenotypes point to developmental and glial roles. 
Our initial screen for lethality and gross morphological phenotypes upon ubiquitous and tissue specific gene dos-
age manipulation in the fruit fly identified a large number of quantifiable lethality and morphological phenotypes 
utilizable for the subsequent genetic interaction experiments.
In general, a high frequency of lethality upon ubiquitous but also upon tissue specific dosage manipulation 
underlines both the dosage sensitivity of these genes and their role for developmental processes. This has been 
shown in mouse models before. Ubiquitous knockout of either Zeb225, Tcf426, Mef2c27 or Atrx28 resulted in early 
lethality, while Ube3a brain-specific maternal-deficient mice displayed neurological deficits29. Interestingly, not 
only the loss of the maternal UBE3A copy in Angelman syndrome but also duplication of UBE3A in terms of 
duplication 15q syndrome is associated with a neurodevelopmental and epilepsy phenotype30, thus demonstrating 
bi-directional dosage sensitivity. We observed more frequent and more severe phenotypes upon overexpression 
than upon knockdown. Though knockdown might be a more suitable model for loss-of-function mechanisms, 
it might not always be phenotypically penetrant, particularly with RNA interference approaches as these usually 
leave a residual expression level of 30–50%. Therefore, overexpression screens provide a valuable additional tool 
to investigate gene function31–33 and to generate quantifiable phenotypes.
Contrary to our expectations for NDD-relevant genes, we did not observe consistent synaptic or behavioural 
phenotypes upon pan-neuronal manipulation in the utilized assays. Although all of the investigated genes are 
associated with epilepsy in humans, neither pan-neuronal knockdown nor overexpression of any single condition 
or combination resulted in bang sensitivity, a Drosophila model for seizure susceptibility, where mechanical shock 
can induce hyperactivity, spasms and paralysis34. This might suggest that seizures associated with haploinsuffi-
ciency of these transcriptional regulators might be related to different pathomechanisms from seizure-associated 
ion channel dysfunction which is typically reflected in bang sensitivity in flies35. Interestingly, in accordance 
with our findings, a previous report did not observe bang sensitivity upon neuronal overexpression of Ube3a as 
a model for epilepsy-associated duplications 15q11.2, either, but instead upon glial overexpression concomitant 
with down regulation of an ion pump36. Correlating a glial role of Ube3a between Drosophila and vertebrates 
is, however, difficult due to a discordant imprinting status of Ube3a in Drosophila neurons37, and as in a mouse 
model, Ube3a has shown to be expressed in glia but not to be imprinted there38. However, a possible, so far 
underestimated glial role of Ube3a and other genes investigated in this study would be in accordance with our 
observations that glial overexpression of either Zfh1, Da, XNP or Mef2 resulted in lethality while this was only 
the case for pan-neuronal overexpression of Zfh1 and with reduced penetrance for pan-neuronal overexpres-
sion of Ube3a. Although a relevance of Zfh1/ZEB2, XNP/ATRX or Da for (mainly peripheral) glia development 
and maintenance has been reported or discussed39–43, it has not yet been characterized in detail. Transcriptome 
analysis on cell populations from mouse brain and on human brain tissues summarized in the Brain RNA-Seq 
database indicates expression of all five genes not only in neurons but also in astrocytes, oligodendrocytes and 
microglia, with a higher expression of TCF4, UBE3A and ATRX in fetal compared to mature astrocytes44,45. Our 
observations therefore might suggest not only a role of neuronal but also of glial defects that might contribute to 
the neurodevelopmental phenotypes in humans with mutations in either of these genes.
Genetic interaction between Ube3a and Mef2. Though the phenotypic overlap between the neurode-
velopmental disorders investigated in this study is widely appreciated and discussed in the literature7,46, corre-
sponding experimental follow-up of possibly underlying molecular commonalities is largely lacking. According 
to the mouse brain atlas47, there is overlapping expression of orthologues of UBE3A, MEF2C, ATRX, ZEB2 and 
TCF4 in several neuronal subtypes including excitatory neurons of the cerebral cortex and various cell types of 
the hippocampus. This would be in line with molecular commonalities in the pathomechanisms of the associated 
NDDs. However, according to the STRING database48 (status July 2019), there is no experimental evidence on 
interaction between the human proteins so far, and available data is restricted to co-expression or interaction in 
other species. In our genetic interaction screen, we observed modification of phenotypes upon combination of 
several manipulated genes. Severe phenotypes such as severe and fully penetrant lethality upon Zfh1 overexpres-
sion precluded further evaluation for genetic interaction. For all other combinations, we observed modified phe-
notypes which might point to a functional link between these proteins in terms of genetic interaction (Table 1). 
Often, only two tissues and/or combinations were involved. More evidence was there for genetic interaction 
between Ube3a and XNP with modified phenotypes in two tissues and three different combinations. Further 
experimental follow-up would be necessary to confirm these potential interactions.
The most stringent evidence for a functional interaction was detected between Ube3a and Mef2. Several lines of 
evidence point to a true genetic interaction: a) we observed modified phenotypes in several tissues and in various 
knockdown/overexpression combinations, b) additive effects only can be excluded as some phenotypes occurred 
only upon pairwise manipulation (e.g. neuronal lethality) or were different or much more severe than expected from 
both single conditions (e.g. eye phenotypes), and c) we observed both antagonistic (milder phenotypes in eyes and 
wings upon simultaneous knockdown of Ube3a and Mef2) and synergistic effects (more severe phenotypes upon all 
other combinations). Additionally, we confirmed a physical interaction between human UBE3A and MEF2C in an 
independent cell-based system. To our knowledge, this is the first evidence for a functional link between UBE3A/
Ube3a and MEF2C/Mef2 that might contribute to the phenotypic overlap between Angelman syndrome and 
MEF2C-associated intellectual disability. Apart from that, variants in either UBE3A or MEF2C might also represent 
modifiers for the phenotypic expression/severity of the respective other condition as discussed for CNV models21,22.
Taking into account the diverse functional roles of UBE3A and MEF2C, there are different possibilities con-
ceivable how their interaction or mutual regulation might work. Observations from the genetic interaction and 
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expression studies might already provide some insights into the possible nature of these interactions. The UBE3A 
gene encodes a member of the large family of E3 ubiquitin ligase proteins, initially termed E6-associated protein 
(E6-AP), and contributing to protein homeostasis by being involved in tagging substrate proteins with ubiquitin 
which are then degraded in the proteasome9. MEF2C (myocyte enhancer factor 2) belongs to the subfamily of 
MADS (MCM1-agamous-deficiens-serum response factor) transcription factors, whose transcriptional activ-
ity relies on the recruitment of and cooperation with other transcription factors as well as on translational and 
posttranslational modifications49. MEF2C might therefore be a transcriptional regulator of UBE3A expression. 
This might be supported by the identification of MEF2 binding sites in the Ube3a promoter50. Vice versa, also 
for UBE3A a transcriptional co-activation function has been reported51. However, a transcriptional regulation 
mechanism appears unlikely as in flies expression levels of Mef2 were unaltered upon Ube3a knockdown and vice 
versa, and as in a human cell line UBE3A knockdown did not change MEF2C expression levels. Additionally, stem 
cell-derived neurons modelling Angelman syndrome, did not show significant transcriptional changes of other 
genes (compared to 15q duplication neurons)52. As the most likely hypothesis, we suggest that UBE3A might reg-
ulate MEF2C activity and levels by ubiquitination, leading to subsequent degradation in the proteasome. UBE3A 
has been found to be located in the neuronal nuclei in discrete hotspots over euchromatin, thus well-positioned 
to regulate active genes24, and such a ubiquitin-ligase-dependent regulation has been reported for other transcrip-
tions factors before in mouse models, e.g. for SOD153. Interestingly, only very recently, the critical importance 
of the nuclear isoform of UBE3A for the Angelman syndrome phenotype was characterized. Mice lacking the 
nuclear isoform but not mice lacking the cytosolic isoform displayed all major behavioural phenotypes and syn-
aptic deficits also seen upon complete UBE3A knockout in the previous Angelman syndrome mouse model54. The 
hypothesis of ubiquitin-ligase dependent regulation of a putative nuclear substrate such as MEF2C by UBE3A is 
also supported by our genetic interaction findings. Pairwise knockdown of Ube3a and Mef2 in the fly resulted in 
antagonistic genetic interaction with ameliorated eye and wing phenotypes. This might be explained by knock-
down of Ube3a leading to decreased ubiquitination and degradation of Mef2. Subsequently increased Mef2 levels 
might result in a partial compensation of the Mef2 knockdown phenotype. All other combinations resulted in 
synergistic genetic interaction, i.e. more severe phenotypes. This would be in line with a) overexpression of Ube3a 
resulting in increased ubiquitination and degradation of Mef2 and thus in a further decrease of its already low 
knockdown levels and b) knockdown of Ube3a resulting in decreased ubiquitination and degradation of Mef2 
and thus in increased Mef2 abundance even above its overexpression levels. The observed interaction of MEF2C 
and UBE3A in co-immunoprecipitation experiments supports such a link. However, specific experimental proof 
of UBE3A regulating MEF2C in an ubiquitin-dependent fashion is still required.
By using Drosophila melanogaster as a model to screen for genetic interactions and by subsequent 
co-immunoprecipitation in a human cell line, we identified a robust interaction between UBE3A/Ube3a and 
MEF2C/Mef2. These molecular commonalities might contribute to the clinically overlapping features of the asso-
ciated disorders.
Material and Methods
Drosophila lines and conditions. Drosophila orthologues of TCF4 (daughterless [CG5102]), ZEB2 (Zfh1 
[CG1322]), MEF2C (Mef2 [CG1429]), ATRX (XNP [CG4548]), and UBE3A (Ube3a [CG6190]) were identi-
fied with DIOPT55. Manipulation of Da/TCF4 in Drosophila has been established as a specific model for PTHS 
previously56.
All RNAi lines and the respective control (VDRC no. 60000) were obtained from the Vienna Drosophila 
Resource Center (VDRC)57. GAL4-driver stocks and transgenic lines for overexpression of Zfh1 and XNP, 
respectively, were obtained from the Bloomington Drosophila Stock Center. UAS-Mef2 was obtained from 
the Zurich ORFeome Project (FlyORF)31, and the UAS-Da line was a gift from Pascal Heitzler (IBMP 
Strasbourg). For generation of the UAS-Ube3a lines, the gene was amplified from fly cDNA (forward: 
5’-GTAAAGTGCGCAGATTTCAGC-3’, reverse: 5’-GGTATCAGTTCCAGATGACAGAC-3’) and cloned into 
a pUAST fly expression vector58. After verification of the sequence, the vector was sent to BestGene Inc. for the 
creation of a stable transgenic line. For a complete list of used Drosophila lines see Supplementary Table S1. All 
overexpression lines were isogenized to the VDRC 60000 control by backcrossing for at least seven generations. 
Double-transgenic fly lines were generated using a double balancer line (Kr/CyO;D/TM6C) (Supplementary 
Table S2). Overexpression or RNAi-mediated knockdown was induced with the UAS-Gal4 system58 and con-
firmed by quantitative RT-PCR (Supplementary Fig. S1). In the text and figures, RNAi-lines are referred to as 
KD_gene, and UAS-lines as OE_gene. Flies were maintained on standard food, containing cornmeal, sugar, agar 
and yeast at 25 °C and bred at 28 °C because of temperature sensitivity of the UAS-GAL4 system59.
Lethality and morphology analysis. RNAi- and transgenic overexpression lines were crossed to five dif-
ferent driver lines: GMR-GAL4 (eye), ms1096-GAL4 (wing), repo-GAL4 (glia cells), elav-GAL4 (pan-neuronal) 
and Actin-GAL4 (II, ubiquitous). Resulting offspring were counted and analysed with a Carl Zeiss™ 2000C stereo 
microscope for gross morphological abnormalities. If the driver line contained a balancer chromosome, offspring 
with balancers were counted, too. In crosses with double OE/KD constructs retaining balancers, the expected 
ratio of balancer to non-balancer offspring may deviate from 50%. Wings and eyes were analysed per fly, and 
a phenotype was counted when it occurred in at least one wing or eye per fly, respectively. Wings were visually 
evaluated for parameters such as shape, degree of unfolding and wing vein structure. Eyes were visually evaluated 
for parameters such as ommatidial structure, bristles and gross size and shape. If applicable, p-values were deter-
mined using Fisher’s Exact test.
Climbing and bang sensitivity assays. Climbing behaviour and bang sensitivity was performed as 
described elsewhere60 upon pan-neuronal manipulation (elav-GAL4). In brief, offspring were collected within 
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72 h of eclosion under CO2 anaesthesia in groups of ten (5 males, 5 females, at least 40 flies tested per genotype). 
After 24 h, flies were transfered to the testing vial, tapped to the bottom and filmed for 30 s while climbing up. 
Time until 70% of the flies had crossed line at 8.8 cm height was measured from the videos. If less than 70% of flies 
from a vial managed to cross the line within the videotaped interval, time was considered to be 30 s. P-values were 
determined using the Wilcoxon-Mann-Whitney test, and Bonferroni correction was applied for multiple testing. 
For testing bang sensitivity, flies were vortexed for 10 s and filmed while recovering. The fraction of flies within a 
vial displaying spasms 5 s after vortexing was determined from the videotapes.
Analysis of neuromuscular junctions (NMJs) from L3 larvae. Analysis of type 1b neuromus-
cular junctions (NMJs) of muscle 4 was performed as previously described60. Male L3 non-GFP larvae upon 
pan-neuronal manipulation (elav-GAL4/CyO-GFP;elav-GAL4) were dissected in PBST, fixated in 4% paraform-
aldehyde and stained with nc82 and anti-discs large antibodies (both from the Developmental Studies Hybridoma 
Bank, Iowa City, IA). Secondary antibodies used were Alexa 488 labeled anti-mouse antibody and the Zenon™ 
Alexa Fluor™ 546 Mouse IgG1 Labeling Kit (ThermoFisher Scientific). Images were taken with a Zeiss Axio 
Imager Z2 microscope in z-stacks and analysed in ImageJ61. NMJ area and length, as well as the number of 
active zones, synaptic islands, branches, and synaptic boutons were determined from the image stacks. Per gen-
otype, at least 11 NMJs from at least four independent larvae were analysed. P-Values were determined using the 
Wilcoxon-Mann-Whitney test, and Bonferroni correction was applied for multiple-testing. Upon Mef2 over-
expression, we observed an additional signal in cross-segmental neurons with Dlg staining (red channel). This 
signal was also present in the parental Mef2 line, in another line from the same background, and was also present 
without Dlg staining (Supplementary Fig. S8). It therefore most likely represents a background signal from the 
RFP gene under control of the artificial 3xP3 promoter present in the Fly ORF lines.
RNA samples. For RNA sampling from flies, whole larvae (~5), adult flies (~4), heads (~10) or larval brains 
(~40) were collected and frozen at −80 °C for at least one hour. Total RNA was isolated with the RNeasy Lipid 
Tissue Mini Kit (Qiagen) using TRIzol™ (ThermoFisher Scientific) instead of QIAzol and QIAshredder col-
umns (Qiagen) for homogenization. DNAse digestion was performed on-column with the RNAse-free DNAse 
kit (Qiagen). Reverse transcription of RNA into cDNA was performed using the SuperScript™ II reverse tran-
scriptase (ThermoFisher Scientific). RNA from HEK293 cells was isolated using the RNeasy Minikit. DNAse 
digestion and reverse transcription was performed as described above.
Quantitative reverse transcriptase PCR (quantitative RT-PCR). Expression analysis was performed 
using the ABsolute QPCR SYBR Green ROX Mix (ThermoFisher Scientific) and (whenever possible) exon 
spanning primers (sequences available on request) on a QuantStudio™ 12 K Flex System (Life Technologies). 
Reactions were performed in quadruplicates, and Ct values were normalized to those of the endogenous controls 
Actin or Tubulin for Drosophila experiments or B2M for experiments on human cells. Relative expression levels 
were obtained using the ∆∆Ct method with isogenic background lines (Drosophila) or cells transfected with 
scrambled siRNA as references. Results were confirmed in at least a second biological replicate.
Immunofluorescence. Expression plasmids expressing human MEF2C and UBE3A and respective negative 
control plasmids were obtained from Sino Biologicals (MEF2C-HA: HG12320-CY, UBE3A-Myc:HG11130-CM, 
pCMV-Myc:CV014 and pCMV-HA:CV013) and used for transient transfection. Transfected HeLa cells were 
grown on poly-lysine coated coverslips, fixated with 4% paraformaldehyde in PBS for 10 minutes and stained 
with anti-Myc (M4439, Sigma-Aldrich) and anti-HA (H6908, Sigma-Aldrich) and with Alexa Fluor™ 488 goat 
anti–mouse and Alexa Fluor™ 488 donkey anti–rabbit antibodies (A11001 and A10040, Thermo Fisher). Nuclei 
were counterstained with DAPI (Serva). Images were taken with a Zeiss Axio Imager Z2 Apotome microscope 
with a 63x objective and analyzed in ImageJ.
Co-Immunoprecipitation. HEK293 cells were transiently transfected with a combination of UBE3A-Myc 
and MEF2C-HA or the respective negative controls and harvested 48 h post transfection. Cells were scraped 
from the culture dish in lysis buffer (100 mM TRIS-HCl pH8, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100). 
Immunoprecipitation was performed with Protein A Mag Sepharose bead suspension (GE Healthcare), incu-
bated with the sample and anti-Myc or anti-HA antibodies (M4439 or H6908, Sigma-Aldrich) at 4 °C overnight. 
Subsequently, beads were washed in lysis buffer, and samples were eluted with 1x Lämmli buffer.
Proteins were separated in stain-free 4–20% Mini-PROTEAN® TGX™ Precast Protein Gels (Bio-Rad), 
blots were stained with anti-Myc and anti-HA antibodies and imaged on a ChemiDoc™ Touch Imaging System 
(Bio-Rad).
siRNA knockdown. Two different siRNAs against UBE3A (Qiagen) were transiently transfected into 
HEK293 cells using jetPrime (Polyplus) according to the manufacturer’s instructions. 48 h post transfection, RNA 
for expression analysis (see description above), was harvested.
Data availability
The datasets generated and/or analyzed during the current study are available from the corresponding author on 
reasonable request.
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